China Pharma Holdings (CPHI) Doubles Q2 Loss to 20c/Share

China Pharma Holdings (NYSE: CPHI) reported Q2 EPS of ($0.20), versus ($0.10) reported last year. Revenue for the quarter came in at $6.1 million, versus $8 million reported last year.

For earnings history and earnings-related data on China Pharma Holdings (CPHI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery